Welcome to the UPF Digital Repository

A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)



A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)

Thumbnail
Document Type: Article
Version: Published version
Date: 2023
This document is associated with a Creative Common license © The authors 2023. This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org.
Thumbnail

This item appears in the following Collection(s)

Search DSpace


Advanced Search

Browse

My Account

Statistics

In collaboration with Compliant to Partaking